Conferences and other presentations
ICEP researchers regularly present their research at conferences and in other talks.
2024
- 20-22 March - International Annual Meeting of the Society for Nicotine and Tobacco Research, Edinburgh, Poster presentation: “Exploring perceptions of sleep, smoking and smoking cessation. A qualitative study with current and ex-smokers”, Angela Attwood and Joe Matthews
- 20-22 March - International Annual Meeting of the Society for Nicotine and Tobacco Research, Edinburgh, Poster presentation: “Evaluating the feasibility of a smartwatch-based smoking relapse intervention”, Angela Attwood and Chris Stone
- 5-8 April - European Association of Urology (EAU) Conference 2024, Paris, France, Plenary presentation: “Prostate cancer: Are we poised for screening? 15-y outcomes of the CAP trial”, Richard Martin
- 24-27 September - World Congress of Epidemiology 2024, Cape Town, South Africa, Oral presentations: “Dissecting the contribution of circulating proteins to multiple myeloma risk: a Mendelian randomization study”, Lucy Goudswaard; "Reassessing the link between adiposity and head and neck cancer: a Mendelian randomization study" and "Further exploring the independent effects of smoking and alcohol use on head and neck cancer: a multivariable Mendelian randomization study", Jasmine Khouja; “Adiposity distribution and risks of twelve obesity-related cancers: a Mendelian randomization analysis” Emma Hazelwood. Read more
- 24-27 September - Sleep Europe Conference, Seville, Spain, Oral presentation: "Assessing the shared genetic architecture of vasomotor symptoms and insomnia during the menopausal transition", Rebecca Richmond
2023
- 15-19 January - Keystone Bioenergetics in Health and Disease, Keystone, USA, Poster presentation: “Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition”, Emma Vincent
- 6 February - 4M Seminar Series on the Genetics of Menopause, Online, Exeter Invited Speaker: “Genetics of Menopause”, Kate Ruth
- 2-3 March - Annual Colorectal Cancer Genetics Consortium (GECCO), Invited Speaker: “Expanding colorectal cancer survival analyses in the GECCO consortium”, Kostas Tsilidis
- 14-17 June - The International Society of Behavioral Nutrition and Physical Activity (ISBNPA) 22nd Annual Meeting, Uppsala, Sweden, Oral presentation: ‘“I’m Hooked on e-cycling, I Can Finally Be Active Again”: Perceptions of e-cycling as a Physical Activity Intervention during Breast Cancer Treatment’, Miranda Armstrong
- 14-17 June - The International Society of Behavioral Nutrition and Physical Activity (ISBNPA) 22nd Annual Meeting, Uppsala, Sweden, Poster: “I'm hooked on e-cycling, I can finally be active again”: Perceptions of e-cycling following a breast cancer diagnosis, Jessica Bourne
- 11-13 September - Society for Nicotine and Tobacco Research Europe Annual Meeting, London, UK, Poster presentation: “Associations between self-reported sleep quality, fatigue severity, smoking relapse risk factors, and cessation beliefs among regular smokers”, Angela Attwood
- 1-5 November - American Society of Human Genetics Annual Meeting 2023, Washington DC, USA, Poster presentation: “Aggregation of 600,000 predictors for cancer risk stratification”, Kevin Liang
- November - Eugin-UPF Chair Symposium, Universitat Pompeu Fabra, Barcelona, Spain, Oral presentation: “Genome-wide analyses of human ovarian ageing: biological mechanisms and insights for population health”, Kate Ruth
- 1-2 December - 10th Panhellenic Conference of Atherosclerosis, Athens, Greece, Invited speaker: “Association of lipidemic profile and cardiovascular disease with cancer”, Kostas Tsilidis
2022
- 15-18 March - Society for Research on Nicotine and Tobacco Baltimore 2022, Baltimore, US, Co-chair, Jasmine Khouja
- 30 March - Diabetes UK Professional Conference, London, UK, Oral presentation: “Taking an interdisciplinary approach to tackle the link between diabetes, obesity and cancer”, Emma Vincent
- 3-5 April - Cell Symposia: Metabolites in Signaling and Disease, Lisbon, Portugal, Poster presentation: “Early metabolic features of colorectal cancer liability”, Caroline Bull
- 23 May - Israel Fertility Association Annual Conference 2022, Tel Aviv, Israel, Invited Speaker: “Insights into human ovarian ageing from genome-wide analyses: Prediction, biological insights and consequences for human health”, Kate Ruth
- 24-25 March - Annual Colorectal Cancer Genetics Consortium (GECCO), Online, Invited Speaker: “Risk factors for colorectal cancer survival: a two-sample Mendelian randomization study”, Kostas Tsilidis
- 8-10 June - Clinical epigenetics international conference, Szczecin, Poland, Poster presentation: “Role of DNA methylation in the relationship between glioma risk factors and glioma incidence: A two-step Mendelian randomization study”, Amy Howell
- 24 June - Democritus University of Thrace, Invited Speaker: “Introduction to Mendelian randomization and applications in biomedicine”, Kostas Tsilidis
- 25-19 October - American Society of Human Genetics Annual Meeting 2022, Los Angeles, USA, Poster presentation: “xWAS findings from GWAS data: a shorter path to causal genes”, Brent Richards
- 11-13 October - Cancer Metabolism 2022, Bilbao, Spain, Poster presentation: “Identifying targetable metabolic dependencies across colorectal cancer progression”, Emma Vincent
- 27 October - 18th World Congress on Menopause, Lisbon, Portugal, Oral presentation: “Insights into the genetic basis of neurokinin 3 receptor signalling from a genomic study of 92,028 women”, Kate Ruth
- October - 2022 Annual Meeting of the International Lung Cancer Consortium, California, US, Oral presentation: “GWAS of pan-cancer survival in Genomics England”, Philip Haycock
- 16-18 November - Epigenomics of Common Diseases Conference 2022, Wellcome Genome Campus, Cambridge, UK, Poster presentation: “Exploring DNA methylation proxies of smoking: characteristics and context”, Ryan Langdon
2021
- European Laboratory Research & Innovation Group
Application of human genetics to improve causality in relationships between the gut microbiome and human disease, Kaitlin Wade - 16th Annual Conference of the Metabolomics Society
The relationships between body mass index and metabolite response to a standardized meal challenge, Caroline Bull - British Neuro-Oncology Society Annual Meeting
Effectiveness of BRAF inhibitors in patients with BRAF-V600 mutation-positive glioma: A systematic review, Zak Thornton
The role of treatments for diabetes and hyperlipidaemia in risk and mortality of primary and secondary brain tumours, Jamie Robinson - ESHG conference
Evidence of a mediating role of fasting insulin, bioavailable testosterone and sex hormone-binding globulin in the relationship between body mass index and endometrial cancer risk: A Mendelian randomization study, Emma Hazelwood - Mendelian Randomization: harnessing the power of population diversity and family relatedness
Circulating Inflammatory Cytokines and Risk of Five Cancers: a Mendelian Randomization Analysis, Emmanouil Bouras; Poster: Evidence of a mediating role of fasting insulin, bioavailable testosterone and sex hormone-binding globulin in the relationship between body mass index and endometrial cancer risk: A Mendelian randomization study, Emma Hazelwood
Metabolic features of genetic liability to colorectal cancer: cohort study with repeated metabolomics across early life, Caroline Bull - European Society of Human Genetics Conference
Causal inference analyses reveal population risks and benefits of extending female reproductive lifespan through manipulation of biological processes, Kate Ruth
The mediatory role of DNA methylation in causal pathways, Rebecca Richmond - World Congress of Epidemiology
Maximising the clinical & public health impact of large-scale, population-based genomic data in cancer, Richard Martin - Society for Research on Nicotine and Tobacco Europe
Exploring the Impact of Unflavoured E-liquids on Perceptions and Intended Use of Cigarettes and E-Cigarettes, Jasmine Khouja - UK Kidney Week conference
Metabolic reprogramming in disease: Can we use genetic epidemiology to guide laboratory studies?, Emma Vincent - International Genetic Epidemiology Society 30th Annual Meeting
Metabolic features of colorectal cancer liability: life course study integrating genetic risk with repeated metabolomics, Caroline Bull - American Society of Human Genetics conference
Germline genetically predicted mammographic density is associated with breast tumor transcriptomic and proteomic features, CD8+ T cell infiltration, somatic mutational signatures, and tumor mutational burden in The Cancer Genome Atlas, Amy Francis - Keystone Tumor Metabolism and the Microenvironment meeting
Examining genetic susceptibility to colorectal cancer in blood: Life course study integrating genetic risk with repeated metabolomics, Caroline Bull - Epigenomics of Common Diseases Conference
Caroline Relton - Epigene2sys conference
Epigenetic modelling of current, former and never smokers, Ryan Langdon